Cell and gene therapies present an enormous opportunity for patients – the ability to insert or adapt genetic material is a true breakthrough for precision medicine and brings hope to those with previously incurable diseases. However, bringing these therapies to patients comes with enormous complexity – from research and approval through manufacturing and administration. In this episode, Jen and Mindy are joined by special guests Karen Baldry and Rebecca Sisselman to discuss the opportunities cell and gene therapies present, the challenges industry partners may be facing, and key considerations for navigating towards success.
For a recent example of Vynamic’s work in cell and gene therapy, check out our case study “Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy (CGT) Biotech”
Podcast Tags: healthcare, life sciences, cell and gene therapy, gene therapy, rare disease, drug launch
Source Links:
Panel – Karen Baldry, Rebecca Sisselman, Mindy McGrath, Jen Burke
Research & Production – Marc Young, Jen Burke
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026,...
Listen now
Todd Quartiere
AI has taken the business world by storm. It’s having a transformative impact on our industry thrilling and challenging in equal measure—shifting how.
Read more
Todd Quartiere
Integrating Artificial Intelligence (AI) across health industry operations was seen as an optional, leading edge only a couple of years ago.....
Read more